Page last updated: 2024-08-21

glycyrrhizic acid and Prostatic Neoplasms

glycyrrhizic acid has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, HY; Chen, SY; Lu, CC; Wu, CH; Yen, GC	1
Byun, S; Dong, Z; Kim, J; Kim, YA; Lee, E; Lee, HJ; Lee, KW; Lee, SJ; Lim, SS; Liu, K; Park, JH; Son, JE	1

Other Studies

2 other study(ies) available for glycyrrhizic acid and Prostatic Neoplasms

Article	Year
Glycyrrhizin Attenuates the Process of Epithelial-to-Mesenchymal Transition by Modulating HMGB1 Initiated Novel Signaling Pathway in Prostate Cancer Cells. Journal of agricultural and food chemistry, 2019, Mar-27, Volume: 67, Issue:12 Topics: Animals; Cadherins; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Glycyrrhizic Acid; HMGB1 Protein; Humans; Male; Prostate; Prostatic Neoplasms; Signal Transduction; Snails	2019
CDK2 and mTOR are direct molecular targets of isoangustone A in the suppression of human prostate cancer cell growth. Toxicology and applied pharmacology, 2013, Oct-01, Volume: 272, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Activation; Fluorescent Antibody Technique; Glycyrrhizic Acid; Humans; Immunohistochemistry; Immunoprecipitation; Indicators and Reagents; Isoflavones; Male; Mice; Mice, Inbred BALB C; Phosphorylation; Prostatic Neoplasms; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2013

Article

Year

Glycyrrhizin Attenuates the Process of Epithelial-to-Mesenchymal Transition by Modulating HMGB1 Initiated Novel Signaling Pathway in Prostate Cancer Cells.

Journal of agricultural and food chemistry, 2019, Mar-27, Volume: 67, Issue:12

Topics: Animals; Cadherins; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Glycyrrhizic Acid; HMGB1 Protein; Humans; Male; Prostate; Prostatic Neoplasms; Signal Transduction; Snails

2019

CDK2 and mTOR are direct molecular targets of isoangustone A in the suppression of human prostate cancer cell growth.

Toxicology and applied pharmacology, 2013, Oct-01, Volume: 272, Issue:1

Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Activation; Fluorescent Antibody Technique; Glycyrrhizic Acid; Humans; Immunohistochemistry; Immunoprecipitation; Indicators and Reagents; Isoflavones; Male; Mice; Mice, Inbred BALB C; Phosphorylation; Prostatic Neoplasms; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2013